The challenging and demanding trial environment calls for sponsors to remain patient centric while at the same time deliver on commercial goals. This mandates sponsors to:

  • Operate more efficiently, delivering high quality data, faster, at a competitive cost to reduce the cost of drugs
  • Operate differently, with collaborative, cost-effective and efficient operating models to deliver increased value from marketed drugs
  • Leverage capabilities of global partners, particularly to access emerging markets

Navitas Life Sciences Is Here to Help

In an age of digital health revolution, Navitas Life Sciences serves as an integrated development partner for faster and more cost-effective management of your Phase II-IV trials. We have served global sponsors in pharma, biotech, medical device, diagnostic, generic and consumer health companies across Europe, US and Asia. Our work has led to long standing relationships of continuous service with leading sponsors. We take pride in being flexible to your specific agendas, giving you the benefit of our:

  • Deep domain experience in helping companies ensure patient safety and navigate international regulations through our medical and regulatory consulting practice
  • Track record of excellence, with more than 40 GCP and non-GCP audits since 2000, with no critical findings
  • Therapeutic experience in challenging disease areas including repeat business for biological, oncology drugs
  • Cost effective global delivery, with local accountability, compliant with all international regulations
  • Optimized and efficient trial conduct and analysis platform, OneClinical
First FDA approved MRI contrast agent for detection and grading of breast cancer, based on two global Phase III trials in 15 countries

Latest News

05
Jul2017

From fifteen to future – Navitas Networks 15 year anniversary

Navitas industry networks recently celebrated its milestone 15th year of delivering insights and creating...